Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Urine Alkalinazation on Urinary Inflammatory Markers Analyzed Using Mass Spectrometry in Patients With Cystinuria

NCT03836144 is registered in ClinicalTrials.gov with European Georges Pompidou Hospital as lead sponsor.

NCT NCT03836144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03836144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Urine Alkalinazation on Urinary Inflammatory Markers Analyzed Using Mass Spectrometry in Patients With Cystinuria
Lead sponsor
European Georges Pompidou Hospital
Phase
Observational
Overall status
Completed
Start date
April 2, 2015
Completion date
December 31, 2020
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystinuria, glomerulonephritis, interstitial nephritis, renal lithiasis